1-4 of 4
Christine Skerka
Close
Sort by
Journal Articles

β 2 -glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator

Katharina Gropp, Nadia Weber, Michael Reuter, Sven Micklisch, Isabell Kopka, Teresia Hallström, Christine Skerka
Journal: Blood
Blood (2011) 118 (10): 2774–2783.
https://doi.org/10.1182/blood-2011-02-339564
Published: 2011
Includes: Supplemental data
Journal Articles

Factor H–related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation

Stefan Heinen, Andrea Hartmann, Nadine Lauer, Ulrike Wiehl, Hans-Martin Dahse, Sylvia Schirmer, Katharina Gropp, Tina Enghardt, Reinhard Wallich, Steffi Hälbich, Michael Mihlan, Ursula Schlötzer-Schrehardt, Peter F. Zipfel, Christine Skerka
Journal: Blood
Blood (2009) 114 (12): 2439–2447.
https://doi.org/10.1182/blood-2009-02-205641
Published: 2009
Includes: Supplemental data
Journal Articles

Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency

Brief Report
Mihály Józsi, Christoph Licht, Stefanie Strobel, Svante L. H. Zipfel, Heiko Richter, Stefan Heinen, Peter F. Zipfel, Christine Skerka
Journal: Blood
Blood (2008) 111 (3): 1512–1514.
https://doi.org/10.1182/blood-2007-09-109876
Published: 2008
Includes: Supplemental data
Journal Articles

Anti–factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome

Brief Report
Mihály Józsi, Stefanie Strobel, Hans-Martin Dahse, Wei-shih Liu, Peter F. Hoyer, Martin Oppermann, Christine Skerka, Peter F. Zipfel
Journal: Blood
Blood (2007) 110 (5): 1516–1518.
https://doi.org/10.1182/blood-2007-02-071472
Published: 2007
Includes: Supplemental data